EDN1 and endothelial dysfunction: Insulin resistance and secondary hyperinsulinaemia amplify endothelial dysfunction, mainly through the imbalance in the bioavailability of the vasodilator substances, such as nitric-oxide, and vasoconstrictor substances, such as endothelin-1.